Xylocaine Injection Recall Due to Hair Contamination
Fresenius Kabi is recalling 93,250 vials of Xylocaine (lidocaine HCl) injection due to the presence of particulate matter, specifically hair found in the product.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving particulate matter (hair) in an injectable drug product. While no illnesses or injuries have been reported, injectable products with foreign particle contamination pose a risk of harm if administered to patients.
Plain-English summary
Fresenius Kabi USA, LLC is recalling 93,250 vials of XYLOCAINE (lidocaine hydrochloride, epinephrine bitartrate) injection, 1%, 200 mg per 20 mL, in 25 multiple-dose vials. The product was distributed nationwide within the USA.
The recall is due to the presence of particulate matter, specifically hair found in the products. The affected lot number is 6130235 with an expiration date of 02/2027.
Healthcare providers and consumers who received the affected product should immediately check their inventory, quarantine any remaining units, and contact Fresenius Kabi to arrange for return or replacement. No illnesses or injuries have been reported in connection with this recall.
The recall was initiated as a precautionary measure after routine testing identified the presence of hair contamination in the injectable product.
The recalled product
- Product
- XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE)
- Brand
- XYLOCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injectable Anesthetic
- Affected units
- 93,250
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 6130235
- Exp. Date 02/2027
UPCs (14)
- 0363323484576
- 0363323485016
- 0363323483036
- 0363323487072
- 0363323486013
- 0363323495091
- 0363323488079
- 0363323489021
- 0363323495046
- 0363323491017
- 0363323492045
- 0363323492090
- 0363323482015
- 0363323481018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Fresenius Kabi USA, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · XYLOCAINE
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighXylocaine injectable anesthetic recalled for temperature abuse during manufacturing
FDA (Drugs) · 2022-06-15
- HighXylocaine Lidocaine Injectable Anesthetic Recalled for Storage Temperature Abuse
FDA (Drugs) · 2022-06-15
- ModerateXylocaine Lidocaine Injection Recalled for Low Epinephrine Assay Results
FDA (Drugs) · 2021-07-14
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
Same hazard · particulate matter
See all →- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26